Literature DB >> 1948650

Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis.

Y Maehara1, S Moriguchi, Y Kakeji, S Kohnoe, D Korenaga, M Haraguchi, K Sugimachi.   

Abstract

From 1965 to 1985, of 1108 patients with advanced gastric cancer who underwent gastric resection in our department, 216 patients (19.5%) had synchronous peritoneal dissemination (PD) or liver metastasis (LM). The 1-year survival rate was 22.5% for PD, 14.7% for LM, and 4.8% for PD plus LM (p less than 0.01). With PD, patients were younger, tumor was larger, Borrmann type 3 and 4 and undifferentiated lesions were more frequent, and the incidence of serosal invasion was higher. Histologic findings showed a pattern of infiltrative growth. With LM, patients were more likely to be male, Borrmann type 2 and 3 and differentiated lesions were frequent, and the antral region was often involved. The degree of serosal invasion was less than with PD. The pattern of growth was the expansive type and vascular involvement was prominent. Rate of lymph node metastasis was high in both groups. The route of metastasis was partly linked to features of the primary lesion. Multivariate analysis showed that independent risk factors involved in the occurrence of each metastasis are serosal invasion, lymph node metastasis, and undifferentiated tissue type for PD, and lymph node metastasis and vascular involvement for LM. When designing treatment in an attempt to suppress a recurrence, even after curative resection, all of these risk factors must be kept in mind.

Entities:  

Mesh:

Year:  1991        PMID: 1948650

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  22 in total

Review 1.  Strategies for treating liver metastasis from gastric cancer.

Authors:  Yoshihiro Kakeji; Masaru Morita; Yoshihiko Maehara
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

2.  Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma.

Authors:  Abeezar I Sarela; Thomas J Miner; Martin S Karpeh; Daniel G Coit; David P Jaques; Murray F Brennan
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

3.  Hepatic resection for metastatic tumors from gastric cancer.

Authors:  Keiichi Okano; Takashi Maeba; Ken Ishimura; Yukihiko Karasawa; Fuminori Goda; Hisao Wakabayashi; Hisashi Usuki; Hajime Maeta
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

4.  Time to death and pattern of death in recurrence following curative resection of gastric carcinoma: analysis based on depth of invasion.

Authors:  Eigo Otsuji; Yoshiaki Kuriu; Daisuke Ichikawa; Kazuma Okamoto; Toshiya Ochiai; Akeo Hagiwara; Hisakazu Yamagishi
Journal:  World J Surg       Date:  2004-09       Impact factor: 3.352

5.  Hepatectomy Offers Superior Survival Compared with Non-surgical Treatment for ≤ 3 Metastatic Tumors with Diameters < 3 cm from Gastric Cancer: A Retrospective Study.

Authors:  Yu Ohkura; Hisashi Shinohara; Shusuke Haruta; Masaki Ueno; Masaji Hashimoto; Yoshiharu Sakai; Harushi Udagawa
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

6.  Smad interacting protein 1 (SIP1) is associated with peritoneal carcinomatosis in intestinal type gastric cancer.

Authors:  Yoshinaga Okugawa; Yasuhiro Inoue; Koji Tanaka; Mikio Kawamura; Susumu Saigusa; Yuji Toiyama; Masaki Ohi; Keiichi Uchida; Yasuhiko Mohri; Masato Kusunoki
Journal:  Clin Exp Metastasis       Date:  2012-11-11       Impact factor: 5.150

7.  Obstructive jaundice in gastric carcinoma: cause, site, and relationship to the primary lesion.

Authors:  B H Lee; S Y Chin; S A Kim; K H Kim; Y S Do
Journal:  Abdom Imaging       Date:  1995 Jul-Aug

8.  Reg IV enhances peritoneal metastasis in gastric carcinomas.

Authors:  H Kuniyasu; N Oue; T Sasahira; L Yi; Y Moriwaka; T Shimomoto; K Fujii; H Ohmori; W Yasui
Journal:  Cell Prolif       Date:  2009-02       Impact factor: 6.831

9.  High survival in patients operated for small isolated liver metastases from gastric cancer: a multi-institutional study.

Authors:  Koji Komeda; Michihiro Hayashi; Shoji Kubo; Hiroaki Nagano; Takuya Nakai; Masaki Kaibori; Hiroshi Wada; Shigekazu Takemura; Masahiko Kinoshita; Chikato Koga; Masataka Matsumoto; Tatsuma Sakaguchi; Yoshihiro Inoue; Fumitoshi Hirokawa; A-Hon Kwon; Kazuhisa Uchiyama
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

10.  Postoperative chemotherapy including intraperitoneal and intradermal administration of the streptococcal preparation OK-432 for patients with gastric cancer and peritoneal dissemination: a prospective randomized study.

Authors:  K Sugimachi; Y Maehara; K Akazawa; Y Kondo; Y Kunii; M Kitamura; H Yamaoka; Y Takahashi; T Kito; M Katou
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.